These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18627432)

  • 41. Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice.
    Jawhar S; Wirths O; Schilling S; Graubner S; Demuth HU; Bayer TA
    J Biol Chem; 2011 Feb; 286(6):4454-60. PubMed ID: 21148560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors.
    Dileep KV; Sakai N; Ihara K; Kato-Murayama M; Nakata A; Ito A; Sivaraman DM; Shin JW; Yoshida M; Shirouzu M; Zhang KYJ
    Int J Biol Macromol; 2021 Feb; 170():415-423. PubMed ID: 33373636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo.
    Shih YP; Chou CC; Chen YL; Huang KF; Wang AH
    PLoS One; 2014; 9(4):e94812. PubMed ID: 24733552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
    Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
    J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template.
    Tran PT; Hoang VH; Thorat SA; Kim SE; Ann J; Chang YJ; Nam DW; Song H; Mook-Jung I; Lee J; Lee J
    Bioorg Med Chem; 2013 Jul; 21(13):3821-30. PubMed ID: 23643900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.
    Paula-Lima AC; Tricerri MA; Brito-Moreira J; Bomfim TR; Oliveira FF; Magdesian MH; Grinberg LT; Panizzutti R; Ferreira ST
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1361-70. PubMed ID: 19130896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
    Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF
    Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
    Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
    Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics.
    Stephan A; Wermann M; von Bohlen A; Koch B; Cynis H; Demuth HU; Schilling S
    FEBS J; 2009 Nov; 276(22):6522-36. PubMed ID: 19804409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An overview of glutaminyl cyclase inhibitors for Alzheimer's disease.
    Coimbra JR; Sobral PJ; Santos AE; Moreira PI; Salvador JA
    Future Med Chem; 2019 Dec; 11(24):3179-3194. PubMed ID: 31838899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.
    Russo O; Cachard-Chastel M; Rivière C; Giner M; Soulier JL; Berthouze M; Richard T; Monti JP; Sicsic S; Lezoualc'h F; Berque-Bestel I
    J Med Chem; 2009 Apr; 52(8):2214-25. PubMed ID: 19334715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains.
    Zhang T; Pan BS; Zhao B; Zhang LM; Huang YL; Sun FY
    Neuroscience; 2009 Jul; 161(4):1045-56. PubMed ID: 19376202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation].
    Iwata N; Asai M
    Rinsho Shinkeigaku; 2012; 52(11):1162-4. PubMed ID: 23196550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Glutaminyl Cyclase Genes Involved in Pyroglutamate Modification of Fungal Lignocellulolytic Enzymes.
    Wu VW; Dana CM; Iavarone AT; Clark DS; Glass NL
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of the Glutaminyl Cyclase Inhibitor PQ912 (Varoglutamstat) and the Murine Monoclonal Antibody PBD-C06 (m6) Shows Additive Effects on Brain Aβ Pathology in Transgenic Mice.
    Hoffmann T; Rahfeld JU; Schenk M; Ponath F; Makioka K; Hutter-Paier B; Lues I; Lemere CA; Schilling S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
    Kim CY; Lee C; Park GH; Jang JH
    Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.
    Matos M; Augusto E; Oliveira CR; Agostinho P
    Neuroscience; 2008 Oct; 156(4):898-910. PubMed ID: 18790019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.